Suppr超能文献

鸟苷酸环化酶/利钠肽受体-A 信号通路拮抗磷酸肌醇水解、钙离子释放和蛋白激酶 C 的激活。

Guanylyl cyclase/natriuretic peptide receptor-A signaling antagonizes phosphoinositide hydrolysis, Ca(2+) release, and activation of protein kinase C.

机构信息

Department of Physiology, School of Medicine, Tulane University Health Sciences Center New Orleans, LA, USA.

出版信息

Front Mol Neurosci. 2014 Aug 22;7:75. doi: 10.3389/fnmol.2014.00075. eCollection 2014.

Abstract

Thus far, three related natriuretic peptides (NPs) and three distinct sub-types of cognate NP receptors have been identified and characterized based on the specific ligand binding affinities, guanylyl cyclase activity, and generation of intracellular cGMP. Atrial and brain natriuretic peptides (ANP and BNP) specifically bind and activate guanylyl cyclase/natriuretic peptide receptor-A (GC-A/NPRA), and C-type natriuretic peptide (CNP) shows specificity to activate guanylyl cyclase/natriuretic peptide receptor-B (GC-B/NPRB). All three NPs bind to natriuretic peptide receptor-C (NPRC), which is also known as clearance or silent receptor. The NPRA is considered the principal biologically active receptor of NP family; however, the molecular signaling mechanisms of NP receptors are not well understood. The activation of NPRA and NPRB produces the intracellular second messenger cGMP, which serves as the major signaling molecule of all three NPs. The activation of NPRB in response to CNP also produces the intracellular cGMP; however, at lower magnitude than that of NPRA, which is activated by ANP and BNP. In addition to enhanced accumulation of intracellular cGMP in response to all three NPs, the levels of cAMP, Ca(2+) and inositol triphosphate (IP3) have also been reported to be altered in different cells and tissue types. Interestingly, ANP has been found to lower the concentrations of cAMP, Ca(2+), and IP3; however, NPRC has been proposed to increase the levels of these metabolic signaling molecules. The mechanistic studies of decreased and/or increased levels of cAMP, Ca(2+), and IP3 in response to NPs and their receptors have not yet been clearly established. This review focuses on the signaling mechanisms of ANP/NPRA and their biological effects involving an increased level of intracellular accumulation of cGMP and a decreased level of cAMP, Ca(2+), and IP3 in different cells and tissue systems.

摘要

迄今为止,已经根据特定的配体结合亲和力、鸟苷酸环化酶活性和细胞内 cGMP 的产生,鉴定和表征了三种相关的利钠肽 (NP) 和三种不同的同源 NP 受体亚型。心房利钠肽 (ANP) 和脑利钠肽 (BNP) 特异性结合并激活鸟苷酸环化酶/利钠肽受体-A (GC-A/NPRA),C 型利钠肽 (CNP) 特异性激活鸟苷酸环化酶/利钠肽受体-B (GC-B/NPRB)。所有三种 NP 都与利钠肽受体-C (NPRC) 结合,NPRC 也称为清除或沉默受体。NPRA 被认为是 NP 家族的主要生物活性受体;然而,NP 受体的分子信号机制尚不清楚。NPRA 和 NPRB 的激活产生细胞内第二信使 cGMP,它是所有三种 NP 的主要信号分子。CNP 对 NPRB 的激活也会产生细胞内 cGMP;然而,其幅度低于 ANP 和 BNP 激活的 NPRA。除了对所有三种 NP 的反应导致细胞内 cGMP 积累增加外,还报道了不同细胞和组织类型中 cAMP、Ca(2+) 和肌醇三磷酸 (IP3) 的水平也发生了改变。有趣的是,ANP 被发现降低 cAMP、Ca(2+) 和 IP3 的浓度;然而,NPRC 被提出增加这些代谢信号分子的水平。NP 和它们的受体对 cAMP、Ca(2+) 和 IP3 的水平降低和/或增加的机制研究尚未明确建立。本综述重点介绍了 ANP/NPRA 的信号机制及其生物学效应,涉及细胞内 cGMP 积累水平增加和不同细胞和组织系统中 cAMP、Ca(2+) 和 IP3 水平降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8cd/4141235/acecce38d185/fnmol-07-00075-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验